Abstract:Abstract The platensimycin (PTM), platencin (PTN), and platensilin (PTL) family of natural products continues to inspire the discovery of new chemistry, enzymology, and medicine. Engineered production of this emerging family of natural products, however, remains laborious due to the lack of practical systems to manipulate their biosynthesis in the native-producing Streptomyces platensis species. Here we report solving this technology gap by implementing a CRISPR-Cas9 system in S. platensis CB00739 to develop an expedient method to manipulate the PTM, PTN, and PTL biosynthetic machinery in vivo. We showcase the utility of this technology by constructing designer recombinant strains S. platensis SB12051, SB12052, and SB12053, which, upon fermentation in the optimized PTM-MS medium, produced PTM, PTN, and PTL with the highest titers at 836 mg L−1, 791 mg L−1, and 40 mg L−1, respectively. Comparative analysis of these resultant recombinant strains also revealed distinct chemistries, catalyzed by PtmT1 and PtmT3, two diterpene synthases that nature has evolved for PTM, PTN, and PTL biosynthesis. The ΔptmR1/ΔptmT1/ΔptmT3 triple mutant strain S. platensis SB12054 could be envisaged as a platform strain to engineer diterpenoid biosynthesis by introducing varying ent-copalyl diphosphate-acting diterpene synthases, taking advantage of its clean metabolite background, ability to support diterpene biosynthesis in high titers, and the promiscuous tailoring biosynthetic machinery. One-Sentence Summary Implementation of a CRISPR-Cas9 system in Streptomyces platensis CB00739 enabled the construction of a suite of designer recombinant strains for the overproduction of platensimycin, platencin, and platensilin, discovery of new diterpene synthase chemistries, and development of platform strains for future diterpenoid biosynthesis engineering.

Review of Platensimycin and Platencin: Inhibitors of β-Ketoacyl-acyl Carrier Protein (ACP) Synthase III (FabH)

Recent Advances On Platensimycin: A Potential Antimicrobial Agent

Asymmetric Synthesis and Biological Evaluation of Platensilin, Platensimycin, Platencin, and Their Analogs Via a Bioinspired Skeletal Reconstruction Approach.

Synthesis and Antimicrobial Evaluation of Novel Platensimycin Analogues

Semisynthesis and Biological Evaluation of Platencin Thioether Derivatives: Dual FabF and FabH Inhibitors against MRSA

Platensimycin and platencin: Inspirations for chemistry, biology, enzymology, and medicine

In Vivo Instability of Platensimycin and Platencin: Synthesis and Biological Evaluation of Urea- and Carbamate-Platensimycin.

Mechanisms of Self-Resistance in the Platensimycin- and Platencin-Producing Streptomyces platensis MA7327 and MA7339 Strains

Total synthesis and antibacterial properties of carbaplatensimycin.

Total Synthesis of (−)-Platensimycin, a Novel Antibacterial Agent

Dedicated Ent-Kaurene and Ent-Atiserene Synthases for Platensimycin and Platencin Biosynthesis

Design, Synthesis, and Biological Evaluation of Platensimycin Analogues with Varying Degrees of Molecular Complexity.

Antibacterial sulfur-containing platensimycin and platencin congeners from Streptomyces platensis SB12029.

Platensimycin-Encapsulated Poly(lactic- co-glycolic acid) and Poly(amidoamine) Dendrimers Nanoparticles with Enhanced Anti-Staphylococcal Activity in Vivo

Structural characterization of β‐ketoacyl ACP synthase I bound to platencin and fragment screening molecules at two substrate binding sites

Chemoenzymatic Syntheses of Some Analogues of the Tricarbocyclic Core of the Anti-Bacterial Agent Platencin and the Biological Evaluation of Certain of Their N-Arylpropionamide Derivatives

Evaluation of Platensimycin and Platensimycin-Inspired Thioether Analogues Against Methicillin-Resistant Staphylococcus Aureus in Topical and Systemic Infection Mouse Models

Bacterial Β-Ketoacyl-acyl Carrier Protein Synthase III (fabh) As a Target for Novel Antibacterial Agents Design

Development of platensimycin, platencin, and platensilin overproducers by biosynthetic pathway engineering and fermentation medium optimization

Novel FabH inhibitors: a patent and article literature review (2000--2012).

[Progress in Streptothricin Antibiotics - A Review].